Recent investigations have the potential of ABX-IL8, the unique compound engineered to selectively block interleukin-8 (IL-8), this important signaling molecule contributing in multiple pathological diseases . In contrast with broad-spectrum approaches website , ABX-IL8 offers this targeted action to neutralize IL-8 activity , potentially resulting